The Parkinson's Virtual Biotech: hope for treating dyskinesia (NLX112)

Dr Arthur Roach, Director of the Parkinson’s Virtual Biotech at Parkinson's UK, and Dr Adrian Newman-Tancredi, CEO and Co-founder of Neurolixis, discuss a pioneering partnership that has led to hopeful results from a clinical trial of NLX112.
For more information, visit www.parkinsons.org.uk/virtual...

[@SoultalkOG]

Funny how you limit you comments on some of these video. I wonder why. Is it because we know that cbd can give relief to people with Parkinson’s and the UK officials refuse to accept this? Hiding the truth? How can anyone with care for other humans want to limit something that has been show to help with symptoms? Greed, money, and materialism will be the downfall of us.

[@stephanedoly3889]

yeah... you or your gand ma, can also take MDMA...it's efficient for PD.....